Results 161 to 170 of about 57,820 (197)
Can non-fundable trials be conducted anyway? The case for open, randomised, actively controlled trials in rheumatology [PDF]
, 1998 E. H GIANNINI
openalex +1 more source
Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma
Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley +1 more source
Arthritis &Rheumatology, EarlyView.Objective Despite the availability of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit +13 more
wiley +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Arthritis &Rheumatology, EarlyView.Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen +2 more
wiley +1 more source
Grand rounds in rheumatology: acute rheumatic fever or post- streptococcal reactive arthritis: a clinical problem revisited [clinical conference] [PDF]
, 1998 Tim Jansen, M. Janssen, P.L. van Riel
openalex +1 more source
Arthritis &Rheumatology, EarlyView.Objective We aimed to evaluate the influence of contrast‐enhanced dual‐energy computed tomography (CE‐DECT) in detecting and differentiating rheumatic joint diseases of the hand. Methods In this prospective study, patients with suspected arthritis of the hand were investigated consecutively alongside the standard clinical procedure.
Sevtap Tugce Ulas +9 more
wiley +1 more source